全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Luca Cindolo , Clara Natoli , Cosimo De Nunzio ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:To evaluate the safety and efficacy of abiraterone acetate (AA) in the “real life” clinical practice for men with chemotherapy-naïve metastatic castration-resistant prostate.
作者:Kouji Izumi , Atsushi Mizokami , Mikio Namiki ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:Both enzalutamide and abiraterone have demonstrated improved radiographic progression-free and overall survival for castration-resistant prostate cancer (CRPC) compared with placebo controls before docetaxel treatment in phase III studies. These oral agents target androgen and an...
作者:Carsten-Henning Ohlmann , Michelle Jäschke , Peter Jaehnig ...
来源:[J].Trials(IF 2.206), 2017, Vol.18 (1)Springer
摘要:The value of continuation of luteinizing hormone-releasing hormone (LHRH) therapy in castration-resistant prostate cancer (CRPC) remains controversial and clear evidence is lacking. Argumentation for cessation of LHRH therapy is the prolonged suppression of testosterone leve...
作者:Yoshinori Yanai , Takeo Kosaka , Hiroshi Hongo ...
来源:[J].BMC Cancer(IF 3.333), 2019, Vol.19 (1), pp.1-4DOAJ
摘要:... Case presentation A 66-year-old man presented with a fever and dyspnea after treatment with cabazitaxel for castration-resistant prostate cancer. He was treated with an intravenous broad-spectrum antimicrobial agent, however he complained of dyspnea and had a pulse oximetr...
作者:Nancy Devlin , Michael Herdman , Marco Pavesi ...
来源:[J].Health and Quality of Life Outcomes(IF 2.272), 2017, Vol.15 (1)Springer
摘要:The effect of enzalutamide on health-related quality of life (HRQoL) in the PREVAIL trial in chemotherapy-naïve men with metastatic castration-resistant prostate cancer was analyzed using the generic EQ-5D instrument.
作者:Liang Y , Mafuvadze B , Aebi JD ...
来源:[J].OncoTargets and Therapy(IF 2.073), 2016, Vol.2016 (Issue 1), pp.3223-3232DOAJ
摘要:... Exposure of both hormone-dependent and castration-resistant human prostate cancer cells to RO reduced prostate cancer cell viability and induced apoptosis in vitro. RO treatment reduced androgen receptor protein expression in hormone-dependent prostate cancer cells and incr...
作者:Takeo Kosaka , Hiroshi Hongo , Mototsugu Oya
来源:[J].BMC Cancer(IF 3.333), 2019, Vol.19 (1), pp.1-3DOAJ
摘要:Abstract Background Cabazitaxel (CBZ) chemotherapy for metastatic castration-resistant prostate cancer (mCRPC) is believed to be palliative because the radiological response rate is low and a durable response is rare. Here, we describe a rare case of a patient with mCRPC who was ...
作者:Osama Ali Arshad , Aniruddha Datta
来源:[J].BMC Bioinformatics(IF 3.024), 2017, Vol.18 (4)Springer
摘要:... A particularly virulent form of this disease is castration-resistant prostate cancer (CRPC), where patients no longer respond to medical or surgical castration. CRPC is a complex, multifaceted and heterogeneous malady with limited standard treatment options.
作者:Linjie Chen , Dennis W. Wolff , Yan Xie ...
来源:[J].BMC Cancer(IF 3.333), 2017, Vol.17 (1)Springer
摘要:Virtually all prostate cancer deaths occur due to obtaining the castration-resistant phenotype after prostate cancer cells escaped from apoptosis and/or growth suppression initially induced by androgen receptor blockade. TNF-related apoptosis-inducing ligand (TRAIL) was an attrac...
作者:Darren M. C. Poon , Kuen Chan , S. H. Lee ...
来源:[J].BMC Urology(IF 1.694), 2016, Vol.16 (1)Springer
摘要:... We report the clinical outcome of metastatic castration-resistant prostate cancer (mCRPC) patients treated with AA in real-life clinical practice.(#br) Methods(#br)The clinical records of mCRPC patients treated with AA from all 6 public oncology centers in Hong Kong between ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×